FDA
- Status: approved
🇺🇸 Triple therapy for 14 days in United States
Triple therapy for 14 days (Triple therapy for 14 days) regulatory status in United States.
Marketing authorisation
Triple therapy for 14 days in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Triple therapy for 14 days approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Triple therapy for 14 days in United States?
National Taiwan University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.